Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation, total small business set-aside

CDER Division of Applied Regulatory Science’s (DARS) Purchase of Cryopreservation System

75F40124Q00543

Food and Drug Administration, FDA Office of Acq Grant SVCS. Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing.

45 open like this View on SAM.gov Markdown

Response deadline

September 18, 2024 at 2:00 PM EDT

Closed 774 days ago. Posted September 12, 2024. Scheduled to archive October 10, 2024.

Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities

This one closed in 2024

45 like it are open now in air-conditioning and warm air heating equipment and commercial and industrial refrigeration equipment manufacturing

All 45 open in air-conditioning and warm air heating equipment and commercial and industrial refrigeration equipment manufacturing

Description

As published on SAM.gov.

The objective of this project is the purchase of an additional high-performance cryopreservation freezer to complement our older existing MVE freezers thereby enhancing overall cryogenic storage capacity while reducing downtime caused by maintenance issues with older freezers. The new cryogenic freezer must be compatibility with our older existing cryogenic MVE Biological Solutions (MVE) systems in terms of storage conditions in order to minimize study to study variations.

The high-performance cryopreservation characteristics of MVE systems will provide multiple benefits over conventional systems including but not limited to holding temperatures stable from top to bottom of vacuum vessel sealing cork top for near 100% enclosure, keeping the samples and liquid nitrogen separate and ease of access so maintenance can be performed without moving samples.

The new system’s benefits will ensure that samples collected from projects in DARS including drug metabolism, invitro drug testing, pharmacokinetic, pharmacodynamic and toxicology studies are stored safely and that storage conditions are identical between the new and existing cryogenic freezers.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 12, 2024

    Combined synopsis and solicitation

    Due September 18, 2024 at 2:00 PM EDT. SAM.gov, notice 0cba3dba5e0a41b899a95388c667ea58

Points of contact